Sharecare, Inc. - Class A Common Stock (NQ:SHCR)

1.430 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 21, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sharecare, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

SHCR LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Sharecare, Inc. Investors to Inquire About Securities Class Action Investigation – SHCR

April 15, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

Sharecare teams up with Anthem Blue Cross and Blue Shield on Jump Shot for Health initiative to support Georgia Title 1 schools

April 11, 2024

From Sharecare, Inc.

Via GlobeNewswire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Sharecare, Inc. (SHCR) on Behalf of Investors

April 05, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

Recap: Sharecare Q4 Earnings ↗

March 28, 2024

Via Benzinga

Sharecare's Earnings Outlook ↗

March 27, 2024

Via Benzinga

Earnings Outlook For Sharecare ↗

March 12, 2024

Via Benzinga

Why Shares of Sharecare Are Soaring on Wednesday ↗

October 11, 2023

The company's stock climbed after a proposal by a private equity firm to buy up available stock.

Via The Motley Fool

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Sharecare, Inc. (SHCR) on Behalf of Investors

April 05, 2024

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Sharecare, Inc. (SHCR) on Behalf of Investors

April 03, 2024

From Law Offices of Frank R. Cruz

Via Business Wire

Berman Tabacco Announces Investigation of Sharecare, Inc. (SHCR) for Potential Securities Law Violations

April 03, 2024

From Berman Tabacco

Via GlobeNewswire

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Sharecare, Inc. (SHCR)

April 02, 2024

From Kirby McInerney LLP

Via GlobeNewswire

SHARECARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Sharecare, Inc. on Behalf of Sharecare Stockholders and Encourages Investors to Contact the Firm

April 01, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sharecare, Inc. and Encourages Investors with Losses to Contact the Firm

April 01, 2024

From Schall Law

Via GlobeNewswire

Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 01, 2024

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 01, 2024

Via Benzinga

SHCR Stock Earnings: Sharecare Beats EPS, Misses Revenue for Q4 2023 ↗

March 28, 2024

SHCR stock results show that Sharecare beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Sharecare announces fourth quarter and full year 2023 financial results and operational highlights

March 28, 2024

From Sharecare, Inc.

Via GlobeNewswire

Earnings Scheduled For March 28, 2024 ↗

March 28, 2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

Via Benzinga

Sharecare to report fourth quarter and full year fiscal 2023 financial results on Thursday, March 28

March 27, 2024

From Sharecare, Inc.

Via GlobeNewswire

Earnings Scheduled For March 13, 2024 ↗

March 13, 2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.

Via Benzinga

Sharecare provides strategic update

March 12, 2024

Independent special committee of the Sharecare Board of Directors reviewing multiple proposals

From Sharecare, Inc.

Via GlobeNewswire

Sharecare reschedules issuance of fourth quarter and full year 2023 earnings release and investor conference call

March 12, 2024

From Sharecare, Inc.

Via GlobeNewswire

Sharecare to report fourth quarter and full year fiscal 2023 financial results on Wednesday, March 13

February 22, 2024

From Sharecare, Inc.

Via GlobeNewswire

Sharecare to present at 42nd Annual J.P. Morgan Healthcare Conference

December 22, 2023

From Sharecare, Inc.

Via GlobeNewswire

Sharecare wins 22 Digital Health Awards in Fall 2023 competition

December 07, 2023

Company bestowed seven awards for its solutions for large employers and health plans, including its proprietary digital therapeutics and flagship well-being and health navigation platform

From Sharecare, Inc.

Via GlobeNewswire

Sharecare announces longtime Centene executive Brent Layton as next CEO; founder Jeff Arnold to serve as executive chairman

November 09, 2023

Announced in conjunction with Sharecare’s strong third quarter 2023 financial results, Layton to assume new role on Jan. 2, 2024

From Sharecare, Inc.

Via GlobeNewswire

Sharecare announces third quarter 2023 financial results and operational highlights

November 09, 2023

In the quarter, Sharecare exceeds high end of revenue guidance, reports decrease in net loss and record adjusted EBITDA margins

From Sharecare, Inc.

Via GlobeNewswire

Sharecare confirms receipt of unsolicited proposal from Claritas Capital

October 12, 2023

From Sharecare, Inc.

Via GlobeNewswire

Sharecare to report third quarter fiscal 2023 financial results on Thursday, November 9

October 12, 2023

From Sharecare, Inc.

Via GlobeNewswire

E2open, Sharecare And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 12, 2023

U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.